FDA Adverse Event Injury Summary report: N

MINICAP TRANSFER SET

MDR report key: 3854390 · Received June 6, 2014

Report

Report Number
1416980-2014-18253
Event Type
Injury
Date Received
June 6, 2014
Date of Event
May 9, 2014
Report Date
May 12, 2014
Manufacturer
BAXTER HEALTHCARE - MOUNTAIN HOME
Product Code
KDJ
PMA / PMN Number
K882498
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
OH, US
Reporter Occupation
NURSE

Narratives

Additional Manufacturer Narrative · 1

COMPLAINT NO: (B)(4). THIS REPORT INVOLVES THE SAME PATIENT AS IN COMPLAINTS (B)(4). SHOULD ADDITIONAL RELEVANT INFORMATION BECOME AVAILABLE, A SUPPLEMENTAL REPORT WILL BE SUBMITTED.

Additional Manufacturer Narrative · 1

(B)(4). A REVIEW OF ALL BATCH RECORD DOCUMENTS FOR POTENTIALLY ASSOCIATED LOT NUMBERS H13I25011, H13J04064, H13K04070 AND H13L02031 WAS PERFORMED WITH NO ISSUES NOTED DURING THE MANUFACTURING PROCESS. THERE WERE NO DEVIATIONS FROM STANDARD PROCEDURE AND NO EXCEPTIONS RELATED TO THE REPORTED CONDITION WERE NOTED. THE SAMPLE WAS NOT RETURNED FOR EVALUATION; THEREFORE A DEVICE ANALYSIS COULD NOT BE PERFORMED. SHOULD ADDITIONAL RELEVANT INFORMATION BECOME AVAILABLE, A SUPPLEMENTAL REPORT WILL BE SUBMITTED.

Description of Event or Problem · 1

IT WAS REPORTED THAT A PATIENT EXPERIENCED PERITONITIS MANIFESTED AS CLOUDY EFFLUENT AND NOT FEELING WELL COINCIDENT WITH PERITONEAL DIALYSIS (PD) THERAPY. THREE DAYS AFTER THE ONSET, THE PATIENT WAS HOSPITALIZED FOR THE EVENT AND TREATED WITH UNKNOWN ANTIBIOTICS FOR PERITONITIS. THE CAUSE OF PERITONITIS WAS NOT REPORTED. THE PATIENT HAD NOT YET RECOVERED FROM THE PERITONITIS. DIANEAL THERAPIES WERE ONGOING. NO ADDITIONAL INFORMATION IS AVAILABLE. THIS IS REPORTED 3 OF 3.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
332473 MINICAP TRANSFER SET SET, ADMINISTRATION, FOR PERITONEAL DIALYSIS, DISPOSABLE KDJ BAXTER HEALTHCARE - MOUNTAIN HOME

Patients

Seq Age Sex Outcome Treatment
1 71 YR Hospitalization| R HOMECHOICE, CASSETTE, MINICAP| DIANEAL PD4 1.5%, 2.5%, AND 4.25% AMBUFLEX